About this role
About the Role The Marketing Lead for OHBU in Taipei leads Amgen's Oncology & Hematology Marketing team, partnering across Sales, Value Access, Medical, and global/local leaders to execute portfolio strategies and programs that deliver value to patients, customers, and shareholders. What You'll Do
- Lead the Oncology & Hematology Marketing team with clear direction, resources, and coaching to achieve business objectives.
- Collaborate closely with Sales, Value Access, Medical, and local, regional, and global partners to ensure execution of short- and long-term portfolio goals, strategies, and programs, driving meaningful patient and customer impact.
- Shape Amgen's oncology portfolio by identifying and shaping growth opportunities across Oncology, Hematology, Rare Disease, and Biosimilars to expand patient access and enhance the customer experience and engagement.
- Own OHBU strategy, operational matters, and new product launches; ensure seamless strategy implementation and track KPIs to measure brand success at strategic and tactical levels.
- Build patient-centric ecosystems across oncology and hematology by connecting KOLs, treatment centers, patient advocacy groups, diagnostic partners, access stakeholders, and internal cross-functional teams to improve awareness, diagnosis, referral, treatment initiation, and continuity of care.
- Build and lead the team with regular coaching and alignment to drive performance and proficiency.
- Partner with country brand teams, cross-functional partners, and local/global leaders to own the oncology portfolio strategy and related projects.
- Develop a marketing strategy and positioning for the portfolio that aligns with global strategy and local objectives, informed by customer journeys, market insights, and disease knowledge.
- Lead the long-range plan, business planning, and product launch readiness for the assigned portfolio; manage marketing budgets and implement strategies.
- Ensure alignment with global and local objectives to deliver results for patients, customers, and shareholders.